# Everforth Inc: financial statements, quarterly

EFOR · NYSE · CIK 890564 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/efor.md) · [Financials](/companies/efor/financials.md) · [Filings](/companies/efor/filings.md) · [Insiders](/companies/efor/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/efor/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,117](/filings/0000890564-24-000022.md) | [1,074 d](/filings/0000890564-26-000013.md) | [1,049](/filings/0000890564-25-000028.md) | [1,035](/filings/0000890564-25-000039.md) | [1,031](/filings/0000890564-25-000063.md) | [985 d](/filings/0000890564-26-000013.md) | [968](/filings/0000890564-26-000037.md) | [1,021](/filings/0000890564-26-000050.md) | [1,011](/filings/0000890564-25-000063.md) | [980 d](/filings/0000890564-26-000013.md) | [968](/filings/0000890564-26-000037.md) | [1,007](/filings/0000890564-26-000050.md) |
| Cost of revenue | $m | [794](/filings/0000890564-24-000022.md) | [769 d](/filings/0000890564-26-000013.md) | [753](/filings/0000890564-25-000028.md) | [734](/filings/0000890564-25-000039.md) | [731](/filings/0000890564-25-000063.md) | [699 d](/filings/0000890564-26-000013.md) | [693](/filings/0000890564-26-000037.md) | [727](/filings/0000890564-26-000050.md) | [715](/filings/0000890564-25-000063.md) | [697 d](/filings/0000890564-26-000013.md) | [702](/filings/0000890564-26-000037.md) | [722](/filings/0000890564-26-000050.md) |
| Gross profit | $m | [322](/filings/0000890564-24-000022.md) | [305 d](/filings/0000890564-26-000013.md) | [296](/filings/0000890564-25-000028.md) | [301](/filings/0000890564-25-000039.md) | [300](/filings/0000890564-25-000063.md) | [286 d](/filings/0000890564-26-000013.md) | [275](/filings/0000890564-26-000037.md) | [293](/filings/0000890564-26-000050.md) | [297](/filings/0000890564-25-000063.md) | [284 d](/filings/0000890564-26-000013.md) | [267](/filings/0000890564-26-000037.md) | [285](/filings/0000890564-26-000050.md) |
| Selling, general and administrative | $m | [206](/filings/0000890564-24-000022.md) | [204 d](/filings/0000890564-26-000013.md) | [210](/filings/0000890564-25-000028.md) | [206](/filings/0000890564-25-000039.md) | [208](/filings/0000890564-25-000063.md) | [198 d](/filings/0000890564-26-000013.md) | [215](/filings/0000890564-26-000037.md) | [217](/filings/0000890564-26-000050.md) | [212](/filings/0000890564-25-000063.md) | [211 d](/filings/0000890564-26-000013.md) | [224](/filings/0000890564-26-000037.md) | [226](/filings/0000890564-26-000050.md) |
| Operating income | $m | [98.6](/filings/0000890564-24-000022.md) | [83.4 d](/filings/0000890564-26-000013.md) | [70.9](/filings/0000890564-25-000028.md) | [80.4](/filings/0000890564-25-000039.md) | [78.9](/filings/0000890564-25-000063.md) | [74.2 d](/filings/0000890564-26-000013.md) | [46.6](/filings/0000890564-26-000037.md) | [59.6](/filings/0000890564-26-000050.md) | [67.9](/filings/0000890564-25-000063.md) | [56.2 d](/filings/0000890564-26-000013.md) | [27.7](/filings/0000890564-26-000037.md) | [41.1](/filings/0000890564-26-000050.md) |
| Interest expense | $m | [18.5](/filings/0000890564-24-000022.md) | [16.7 d](/filings/0000890564-26-000013.md) | [17.6](/filings/0000890564-25-000028.md) | [15.8](/filings/0000890564-25-000039.md) | [16.0](/filings/0000890564-25-000063.md) | [14.9 d](/filings/0000890564-26-000013.md) | [15.4](/filings/0000890564-26-000037.md) | [18.2](/filings/0000890564-26-000050.md) | [17.4](/filings/0000890564-25-000063.md) | [16.7 d](/filings/0000890564-26-000013.md) | [17.1](/filings/0000890564-26-000037.md) | [20.4](/filings/0000890564-26-000050.md) |
| Income tax | $m | [20.7](/filings/0000890564-24-000022.md) | [16.4 d](/filings/0000890564-26-000013.md) | [15.2](/filings/0000890564-25-000028.md) | [17.4](/filings/0000890564-25-000039.md) | [15.4](/filings/0000890564-25-000063.md) | [16.9 d](/filings/0000890564-26-000013.md) | [10.3](/filings/0000890564-26-000037.md) | [12.1](/filings/0000890564-26-000050.md) | [12.4](/filings/0000890564-25-000063.md) | [14.3 d](/filings/0000890564-26-000013.md) | [5.1](/filings/0000890564-26-000037.md) | [6.5](/filings/0000890564-26-000050.md) |
| Net income | $m | [59.4](/filings/0000890564-24-000022.md) | [50.3 d](/filings/0000890564-26-000013.md) | [38.1](/filings/0000890564-25-000028.md) | [47.2](/filings/0000890564-25-000039.md) | [47.5](/filings/0000890564-25-000063.md) | [42.4 d](/filings/0000890564-26-000013.md) | [20.9](/filings/0000890564-26-000037.md) | [29.3](/filings/0000890564-26-000050.md) | [38.1](/filings/0000890564-25-000063.md) | [25.2 d](/filings/0000890564-26-000013.md) | [5.5](/filings/0000890564-26-000037.md) | [14.2](/filings/0000890564-26-000050.md) |
| Diluted EPS | $ per share | [1.23](/filings/0000890564-24-000022.md) | not reported | [0.81](/filings/0000890564-25-000028.md) | [1.02](/filings/0000890564-25-000039.md) | [1.06](/filings/0000890564-25-000063.md) | not reported | [0.48](/filings/0000890564-26-000037.md) | [0.67](/filings/0000890564-26-000050.md) | [0.87](/filings/0000890564-25-000063.md) | not reported | [0.13](/filings/0000890564-26-000037.md) | [0.35](/filings/0000890564-26-000050.md) |
| Basic EPS | $ per share | [1.23](/filings/0000890564-24-000022.md) | not reported | [0.82](/filings/0000890564-25-000028.md) | [1.03](/filings/0000890564-25-000039.md) | [1.07](/filings/0000890564-25-000063.md) | not reported | [0.48](/filings/0000890564-26-000037.md) | [0.67](/filings/0000890564-26-000050.md) | [0.88](/filings/0000890564-25-000063.md) | not reported | [0.13](/filings/0000890564-26-000037.md) | [0.35](/filings/0000890564-26-000050.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [176](/filings/0000890564-25-000008.md) | not reported | not reported | not reported | [205](/filings/0000890564-26-000013.md) | not reported | not reported | not reported | [161](/filings/0000890564-26-000013.md) | not reported | not reported |
| Current assets | $m | [994](/filings/0000890564-23-000020.md) | [973](/filings/0000890564-25-000008.md) | [933](/filings/0000890564-24-000013.md) | [914](/filings/0000890564-24-000019.md) | [907](/filings/0000890564-24-000022.md) | [918](/filings/0000890564-26-000013.md) | [880](/filings/0000890564-25-000028.md) | [916](/filings/0000890564-25-000039.md) | [918](/filings/0000890564-25-000063.md) | [916](/filings/0000890564-26-000050.md) | [970](/filings/0000890564-26-000037.md) | [988](/filings/0000890564-26-000050.md) |
| Total assets | $m | [3,579](/filings/0000890564-23-000020.md) | [3,545](/filings/0000890564-25-000008.md) | [3,489](/filings/0000890564-24-000013.md) | [3,451](/filings/0000890564-24-000019.md) | [3,432](/filings/0000890564-24-000022.md) | [3,429](/filings/0000890564-26-000013.md) | [3,698](/filings/0000890564-25-000028.md) | [3,715](/filings/0000890564-25-000039.md) | [3,700](/filings/0000890564-25-000063.md) | [3,677](/filings/0000890564-26-000050.md) | [4,028](/filings/0000890564-26-000037.md) | [4,024](/filings/0000890564-26-000050.md) |
| Current liabilities | $m | [443](/filings/0000890564-23-000020.md) | [394](/filings/0000890564-25-000008.md) | [372](/filings/0000890564-24-000013.md) | [390](/filings/0000890564-24-000019.md) | [404](/filings/0000890564-24-000022.md) | [367](/filings/0000890564-26-000013.md) | [372](/filings/0000890564-25-000028.md) | [435](/filings/0000890564-25-000039.md) | [462](/filings/0000890564-25-000063.md) | [424](/filings/0000890564-26-000050.md) | [462](/filings/0000890564-26-000037.md) | [464](/filings/0000890564-26-000050.md) |
| Total liabilities | $m | [1,670](/filings/0000890564-23-000020.md) | [1,653](/filings/0000890564-25-000008.md) | [1,627](/filings/0000890564-24-000013.md) | [1,643](/filings/0000890564-24-000019.md) | [1,657](/filings/0000890564-24-000022.md) | [1,652](/filings/0000890564-26-000013.md) | [1,905](/filings/0000890564-25-000028.md) | [1,888](/filings/0000890564-25-000039.md) | [1,867](/filings/0000890564-25-000063.md) | [1,873](/filings/0000890564-26-000050.md) | [2,239](/filings/0000890564-26-000037.md) | [2,218](/filings/0000890564-26-000050.md) |
| Long-term debt | $m | [1,038](/filings/0000890564-23-000020.md) | [1,037](/filings/0000890564-25-000008.md) | [1,036](/filings/0000890564-24-000013.md) | [1,035](/filings/0000890564-24-000019.md) | [1,034](/filings/0000890564-24-000022.md) | [1,034](/filings/0000890564-26-000013.md) | [1,283](/filings/0000890564-25-000028.md) | [1,212](/filings/0000890564-25-000039.md) | [1,166](/filings/0000890564-25-000063.md) | [1,169](/filings/0000890564-26-000013.md) | [1,462](/filings/0000890564-26-000037.md) | [1,438](/filings/0000890564-26-000050.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,909](/filings/0000890564-24-000022.md) | [1,892](/filings/0000890564-26-000013.md) | [1,861](/filings/0000890564-25-000039.md) | [1,808](/filings/0000890564-25-000063.md) | [1,774](/filings/0000890564-25-000063.md) | [1,777](/filings/0000890564-26-000050.md) | [1,793](/filings/0000890564-26-000050.md) | [1,827](/filings/0000890564-26-000050.md) | [1,833](/filings/0000890564-25-000063.md) | [1,804](/filings/0000890564-26-000050.md) | [1,789](/filings/0000890564-26-000050.md) | [1,805](/filings/0000890564-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [148 d](/filings/0000890564-24-000022.md) | [116 d](/filings/0000890564-26-000013.md) | [73.3](/filings/0000890564-25-000028.md) | [90.7 d](/filings/0000890564-25-000039.md) | [136 d](/filings/0000890564-25-000063.md) | [100 d](/filings/0000890564-26-000013.md) | [16.8](/filings/0000890564-26-000037.md) | [125 d](/filings/0000890564-26-000050.md) | [83.9 d](/filings/0000890564-25-000063.md) | [102 d](/filings/0000890564-26-000013.md) | [18.5](/filings/0000890564-26-000037.md) | [52.2 d](/filings/0000890564-26-000050.md) |
| Capital expenditure | $m | [9.8 d](/filings/0000890564-24-000022.md) | [7.2 d](/filings/0000890564-26-000013.md) | [10.8](/filings/0000890564-25-000028.md) | [5.3 d](/filings/0000890564-25-000039.md) | [7.9 d](/filings/0000890564-25-000063.md) | [11.3 d](/filings/0000890564-26-000013.md) | [10.2](/filings/0000890564-26-000037.md) | [9.1 d](/filings/0000890564-26-000050.md) | [11.9 d](/filings/0000890564-25-000063.md) | [8.6 d](/filings/0000890564-26-000013.md) | [9.4](/filings/0000890564-26-000037.md) | [5.9 d](/filings/0000890564-26-000050.md) |
| Share repurchases | $m | [91.3 d](/filings/0000890564-24-000022.md) | [75.4 d](/filings/0000890564-26-000013.md) | [79.7](/filings/0000890564-25-000028.md) | [108 d](/filings/0000890564-25-000039.md) | [95.6 d](/filings/0000890564-25-000063.md) | [43.9 d](/filings/0000890564-26-000013.md) | [50.4](/filings/0000890564-26-000037.md) | [9.5 d](/filings/0000890564-26-000050.md) | [46.0 d](/filings/0000890564-25-000063.md) | [64.2 d](/filings/0000890564-26-000013.md) | [39.0](/filings/0000890564-26-000037.md) | [11.5 d](/filings/0000890564-26-000050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.7](/filings/0000890564-23-000020.md) | [49.8](/filings/0000890564-24-000013.md) | [49.2](/filings/0000890564-24-000019.md) | [48.4](/filings/0000890564-24-000022.md) | [46.9](/filings/0000890564-25-000028.md) | [46.1](/filings/0000890564-25-000039.md) | [45.0](/filings/0000890564-25-000063.md) | [44.0](/filings/0000890564-26-000037.md) | [44.0](/filings/0000890564-26-000050.md) | [43.7](/filings/0000890564-25-000063.md) | [41.4](/filings/0000890564-26-000037.md) | [41.0](/filings/0000890564-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,000,000 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0000890564-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.